Compass Therapeutics to Present Second Quarter Financial Results and Provide Business Update on August 11, 2025
Call Details:
Date: Monday, August 11, 2025
Time: 8:00 AM ET
Webcast: https://viavid.webcasts.com/starthere.jsp?ei=1727543&tp_key=955a2c2f4d
Dial-In: 1-877-407-9716 (US), 1-201-493-6779 (International), 13754954 (Conference ID)
Virtual/Replay availability: A replay will be archived for 90 days on Compass' Events page.
About Compass Therapeutics
Compass Therapeutics, Inc. is a clinical-stage oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. Compass has built a robust pipeline of novel product candidates designed to target multiple critical biological pathways required for an effective anti-tumor response. These include modulation of the microvasculature via angiogenesis-targeted agents, induction of a potent immune response via activators on effector cells in the tumor microenvironment, and alleviation of immunosuppressive mechanisms used by tumors to evade immune surveillance. The company plans to advance its product candidates through clinical development as both standalone therapies and in combination with proprietary pipeline antibodies based on supportive clinical and nonclinical data. The Company was founded in 2014 and is headquartered in Boston, Massachusetts. For more information, visit the Compass Therapeutics website at https://www.compasstherapeutics.com.
Investor Contactir@compasstherapeutics.comMedia ContactAnna Gifford, Chief of Staffmedia@compasstherapeutics.com617-500-8099Erreur lors de la récupération des données
Connectez-vous pour accéder à votre portefeuille
Erreur lors de la récupération des données
Erreur lors de la récupération des données
Erreur lors de la récupération des données
Erreur lors de la récupération des données
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 minutes ago
- Yahoo
Why Rocket Lab Stock Skyrocketed Today but Fell Back to Earth
Key Points Rocket Lab stock was up as much as 12.9% in today's trading, but it saw a big pullback. The company's second-quarter results delivered sales that far exceeded Wall Street's target. Rocket Lab also posted a larger-than-expected loss in the second quarter, and the company's growth-dependent valuation comes with risk. 10 stocks we like better than Rocket Lab › Shares of Rocket Lab (NASDAQ: RKLB) opened Friday's trading with big gains, but it ended the daily session only modestly in the green. The space-tech company's share price rose 1% in today's trading, but it had been up as much as 12.9% earlier in the day. It published its second-quarter results after the market closed yesterday and initially saw huge bullish momentum in Friday's session. But the stock lost ground as investors took profits and put more focus on the business' wider-than-expected loss last quarter. On the heels of today's modest post-earnings gain, Rocket Lab stock is now up roughly 75% year to date. The stock was volatile but still closed today's trading in the green Rocket Lab stock has been on a big winning streak this year as space commercialization has become a popular play among growth-focused investors, and next-generation defense trends have also helped boost interest in its rocket launch services and related technologies. The company's recent quarterly release represented a significant test for the stock -- and it seems like the long-term bullish thesis is still intact. Revenue increased 36% year over year to reach roughly $144.5 million, beating the average Wall Street analyst forecast by roughly $9.1 million. Revenue was up 36% year over year in the quarter, and the big sales beat was initially enough to power double-digit gains for the stock today before gravity set in. The company significantly outperformed Wall Street's revenue target, but its loss of $0.13 per share last quarter also exceeded the average analyst estimate's call for a narrower loss of $0.11. What's next for Rocket Lab? Rocket Lab's wider-than-expected loss in the second quarter doesn't look particularly concerning in light of sales that also came in substantially higher than analysts and investors had anticipated. The company is still in what looks to be a relatively early growth stage, and its current margin profile means that quarterly sales beats are also likely to arrive with losses that are wider than expected. Valued at roughly 36 times this year's expected sales, Rocket Lab could be poised for volatility -- but the company's long-term opportunities mean the stock warrants a look from growth-focused investors seeking exposure to the space industry. Should you invest $1,000 in Rocket Lab right now? Before you buy stock in Rocket Lab, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Rocket Lab wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $636,563!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,108,033!* Now, it's worth noting Stock Advisor's total average return is 1,047% — a market-crushing outperformance compared to 181% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 4, 2025 Keith Noonan has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Rocket Lab. The Motley Fool has a disclosure policy. Why Rocket Lab Stock Skyrocketed Today but Fell Back to Earth was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 minutes ago
- Yahoo
U.S. in final decision to hike Canadian softwood duties, tells officers to collect
The U.S. Department of Commerce says it has made a final decision to more than double countervailing duties on Canadian softwood lumber imports, a move business groups in British Columbia say will harm communities on both sides of the border. A statement from the American department says the duty for most Canadian companies is being increased to 14.63 per cent, up from 6.74 per cent, after it determined softwood lumber from Canada was being unfairly subsidized. The increase is on top of a recent jump in anti-dumping duties to 20.56 per cent, bring the total duty level for Canadian softwood to 35.19 per cent. The department says it will now instruct U.S. Customs and Border Protection to begin collecting the money. Kurt Niquidet, president of the BC Lumber Trade Council, says in a statement that the decision places unnecessary strain on forestry-dependent regions in Canada while driving up construction costs for American builders. The council says both the Canadian and U.S. governments need to make resolving the long-standing softwood lumber dispute a top economic priority. "In the absence of a negotiated settlement, BCLTC will continue working closely with the Government of Canada and industry partners to defend Canadian interests through all available legal channels, including proceedings under the United States-Mexico-Canada Agreement," the statement says. The BC Council of Forest Industries says the provincial government needs to take action including streamlining permitting processes, activating provincial timber sales and removing cross-ministry bottlenecks. 'With the right policy tools, B.C. can send a strong message that it is committed to creating a climate where primary and secondary forest manufacturers want to invest, ensuring a steady supply of wood products for B.C., Canada, and beyond,' president Kim Haakstad said in a statement. Prime Minister Mark Carney was in B.C. this week promising $700 million in loan guarantees for the industry and $500 million for long-term supports to help companies diversify export markets and develop their products. This report by The Canadian Press was first published Aug. 8, 2025 Ashley Joannou, The Canadian Press
Yahoo
3 minutes ago
- Yahoo
Trump's Tariffs Just Blew Up the Farm Economy--Here's What Investors Need to Know
American farmers may still back President Donald Trump at the ballot box, but his tariff-heavy trade strategy is testing their financial resilience. New levies, layered atop existing ones, have pushed the average U.S. tariff rate to 15.2%its highest since World War II, according to Bloomberg Economics. The timing couldn't be worse. Crop prices for corn, soybeans, and wheat are at post-pandemic lows, and the cost of essentials like fertilizer and tractors is heading in the opposite direction. Mosaic says U.S.-bound shipments of phosphate and potash have dropped 20% year-over-year, while CF Industries (NYSE:CF) flagged incredibly low inventory and delayed imports that still need rebuilding. A North American fertilizer price index has surged 35% this year, driven by tight supply and geopolitical pressure. Warning! GuruFocus has detected 3 Warning Sign with OKLO. That strain is bleeding into the farm machinery sector. Tractor maker AGCO (NYSE:AGCO) confirmed it has already raised prices in North America and may adjust pricing in other regions as the tariff impact deepens. We will implement price increases where appropriate and feasible, said CEO Eric Hansotia. Meanwhile, demand-side stress is starting to show. U.S. soybean sales for the upcoming marketing year are at their lowest point in nearly two decades, with Chinathe biggest buyerstill absent. Bunge (NYSE:BG), a major crop trader, said customers are avoiding long-term contracts, sticking to very spot purchases instead. The company just posted its weakest second-quarter EPS since 2018. While President Trump insists farmers just need to bear with the plan, executives across the ag sector are sounding the alarm. Bert Frost of CF Industries highlighted that crop revenues aren't keeping up with soaring input costs, echoing broader concerns about farm economics in North America. Trump has doubled down on promises to support the rural base, saying on CNBC he's making sure farmers have the labor they need despite ongoing immigration crackdowns. But with fertilizer prices rising, crop buyers holding back, and uncertainty clouding the fall harvest, the costs of waiting could be stacking up faster than many can handle. This article first appeared on GuruFocus. Sign in to access your portfolio
